Cellectis S.A.

IPO

Home | Cellectis

Public · Paris, France · Founded 1999 · $300.0M raised

Headquarters
Paris
Employees
201–500
Founded
1999
Business Model
B2B
Total Funding
$300.0M
Last Round
$140.0M Corporate RoundMay 2024
Rounds
3
Type
Public

About

Founded in 1999, Cellectis is a clinical-stage biopharmaceutical company with 25 years of expertise in gene editing using its proprietary TALEN technology and PulseAgile electroporation system. The company pioneers allogeneic off-the-shelf CAR T-cell therapies (UCART) targeting cancers including B-ALL and non-Hodgkin lymphoma. Cellectis is listed on Nasdaq (CLLS) and Euronext Growth, with operations in Paris, New York, and Raleigh.

Summary

Cellectis S.A. is a Biotech company based in Paris, France, founded in 1999. It has raised $300.0M in total across 3 rounds, most recently a $140.0M Corporate Round in May 2024. Investors include AstraZeneca and Pfizer Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMay 2024
$140.0M

Sign up to see all 4 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellectis S.A. on Indexed.vc
<a href="https://indexed.vc/companies/cellectis-s-a"><img src="https://indexed.vc/api/badge/company/cellectis-s-a" alt="Cellectis S.A. on Indexed.vc" width="260" height="76" /></a>